• 临床论丛 • Previous Articles     Next Articles

The clinical study of median effective dose of ropivacaine for lumbar plexus blockade in elderly patients

  

  • Received:2009-10-29 Revised:2010-03-08 Published:2010-07-15 Online:2010-07-15
  • Contact: Ma Lin

Abstract: The clinical study of median effective dose of ropivacaine for lumbar plexus blockade in elderly patients MA Lin,YangYong, YU Yong-hao Department of Anesthesiology, General Hospital, Tianjin Medical University, Tianjin 300052, China Abstract Objective: To determine the median effective dose(ED50) of ropivacaine for lumbar plexus blockade in elderly patients. Methods:Forty patients ,aged 65~85(n=20) or 18~35(n=20) underwent lumbar plexus and sciatic nerve blockade for operations of unilateral lower extremities. The volume of local anesthetic used in each patient was based on the up-and-down method for lumbar plexus blockade. The ratio of two consecutive dose was 1.12. Successful nerve block was defined as complete loss of pinprick sensation in the femoral nerve distribution , with concomitant inability to extend the affected leg within 30 min after local anesthetic injection. Results:The ED50 of 0.375% ropivacaine was 28.84 ml in the older group and 34.28 ml in the younger group (P<0.05).The 95% confidence interval was 27.42~30.45 ml in the older group and 32.24~35.61 ml in the younger group. Conclusion:The ED50 of ropivacaine for lumbar plexus blockade is significant decrease in elderly patients.

Key words: Ropivacaine, Lumbar plexus, Anesthesia, Median effective dose